Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

The Lancet - Tập 391 Số 10125 - Trang 1023-1075 - 2018
Claudia E. Kuehni1, Takehisa Matsuda2, V Di Carlo1, Rhea Harewood1, M Matz1, Maja Nikšić1, Audrey Bonaventure1, М. Yu. Valkov3, Christopher J. Johnson4, Jordi Esteve5, Olufemi J. Ogunbiyi6, Gulnar Azevedo e Silva7, Wanqing Chen8, Sultan Eser9, Gerda Engholm10, Charles Stiller11, Alain Monnereau12, Ryan Woods13, Otto Visser14, Gek Hsiang Lim15, Joanne F. Aitken16, Hannah K. Weir17, Andrea Micheli1, S. Bouzbid15, M Hamdi-Chérif1, Zoubida Zaidi7, Kaouel Meguenni, D. Regagba, Siné Bayo15, T Cheick Bougadari16, Shyam Manraj14, Karima Bendahhou, A. Fabowale, Debbie Bradshaw, Nontuthuzelo Somdyala, I. Kumcher, Florencia Moreno1, G.H. Calabrano10, S.B. Espinola, B Carballo Quintero1, R Fita, M C Diumenjo, W.D. Laspada, S.G. Ibañez, Carlos Anselmo Lima, POLIANA CACHOEIRA SOUZA, Karina Pino‐Lagos, C. Laporte, María Paula Curado4, José Carlos de Oliveira, Claudia Veneziano1, D.B. Veneziano, M R D O Latorre, Luana Fiengo Tanaka, Marise Souto Rebelo15, M O Santos12, J.C. Galaz, M Aparicio Aravena1, J Sanhueza Monsalve16, D.A. Herrmann, S Torres Vargas15, Víctor Herrera3, Claudia Uribe, Luis Eduardo Bravo1, Luz Stella García, Nelson Enrique Arias-Ortiz16, D Morantes, Daniel Jurado1, María Clara Yépez Chamorro, Sandra Delgado15, Melissa Ramirez1, Y H Galán Alvarez, Priscila Torres, F Martínez-Reyes1, L Jaramillo1, R. Quinto, J Castillo16, M Mendoza1, Eva Ardanáz, J.G. Yépez, Bernard Bhakkan1, Jacqueline Deloumeaux16, Patricia Delafosse, Jonathan Macni16, R Carrillo, Jaime Shalkow‐Klincovstein16, Rebeca Rivera-Gómez, Ebert Poquioma1, Guillermo Tortolero‐Luna, Diego Zavala, R. Alonso, Enrique Barrios1, Angela Eckstrand, C Nikiforuk, G. Noonan, Donna Turner, Eshwar Kumar1, B Zhang1, F.R. McCrate, Susan Ryan13, M Macintyre1, Nathalie Saint‐Jacques, D.E. Nishri, Carol McClure, K.A. Vriends, Serena Kozie15, H. Stuart-Panko1, T Freeman16, J T George, J.T. Brockhouse, David K. O’Brien, Rangaswamy Govindarajan, Lyn Almon1, Sandy Kwong15, Cyllene R. Morris, Randi Rycroft, Lloyd Mueller1, C. Phillips, Heather M. Brown1, B Cromartie1, Ann G. Schwartz, Fawn D. Vigneau1, Gary M. Levin, Brad Wohler1, Rana Bayakly, Kevin C. Ward, Scarlett Lin Gomez, Meg McKinley1, Rosemary D. Cress, M D Green12, Kanoko Miyagi, Laura Ruppert1, Charles F. Lynch, Bowen Huang1, T. C. Tucker, Dennis Deapen, Lihua Liu1, Mei‐Chin Hsieh, Xiao‐Cheng Wu, Molly Schwenn1, Susan T. Gershman11, Richard Knowlton, Georgetta Alverson, G.E. Copeland15, Sally Bushhouse15, D B Rogers, J Jackson-Thompson16, D Lemons, Heather Zimmerman, Michelle M. Hood1, J Roberts-Johnson16, Judy R. Rees, Bruce L. Riddle1, Karen Pawlish1, Antoinette M. Stroup, Charles R. Key, Charles L. Wiggins, Amy R. Kahn, Maria J. Schymura, S Radhakrishnan15, Chandrika Rao, L K Giljahn3, R M Slocumb11, R E Espinoza12, Faiz Ali Khan1, K G Aird, T Beran16, J J Rubertone4, S J Slack, Lucy García1, Denis L. Rousseau, T A Janes16, Stephen M. Schwartz13, S.W. Bolick, Deborah Hurley1, Martin Whiteside1, Paige Miller-Gianturco, Melanie Williams1, Kim Herget, Carol Sweeney, Alison Johnson4, M B Keitheri Cheteri1, Patti Migliore Santiago, S E Blankenship14, S Farley15, R.R. Borchers, R Malicki, J.R. Espinoza, Joseph Grandpre16, Reda Wilson, Brenda K. Edwards, A Mariotto, Yutao Lei13, Na Wang, Jen‐Shi Chen8, Yan Zhou13, Yufang He1, Guili Song10, Xiaoping Gu7, Dan Mei, Huijuan Mu, H M Ge15, T H Wu, Y Y Li15, Di Zhao, Feng Jin1, J H Zhang, F D Zhu, Q Junhua8, Y L Yang, Chunxiao Jiang, Biao Wang, Jia‐Bin Wang16, Q L Li15, Yongzhong He6, Xiangxiang Zhou, Jie Dong16, W Li15, F X Fu, S Z Liu, Jianguo Chen8, Jian Zhu16, Y H Li15, Yu-Qiang Lu6, Min Fan1, Suqin Huang, Guo‐Ping Guo, Hua Zhao-lai1, Kuangrong Wei17, Huiming Zeng1, Anna Demetriou14, W.K. Mang, K.C. Ngan, A.C. Kataki, Manigreeva Krishnatreya1, P A Jayalekshmi, P. Sebastian, A Nandakumar, Reza Malekzadeh, Gholamreza Roshandel, Lital Keinan-Boker1, Barbara Silverman, Hidemi Ito1, Hidenori Nakagawa1, Masako Satô1, F Tobori1, I Nakata, N Teramoto, Masaya Hattori1, Yasuharu Kaizaki13, Fumitaka Moki1, Hiromi Sugiyama1, Mai Utada1, M Nishimura1, K Yoshida, K Kurosawa, Y Nemoto13, Hiroto Narimatsu1, Masahiko Sakaguchi1, Seiki Kanemura15, Michiko Naito1, Rintaro Narisawa, Isao Miyashiro, Kayo Nakata, S Sato15, Mami Yoshii1, Izumi Oki, N Fukushima, Akiko Shibata, K Iwasa, C Ono, Omar Nimri, Kyu‐Won Jung17, Young‐Joo Won, E Alawadhi1, A Elbasmi, Azizah Ab Manan, Farzaana Adam1, E Sanjaajmats1, Undarmaa Tudev18, Chimedsuren Оchir, Amir M Khater1, M.M. El Mistiri15, Yik Ying Teo, Chun‐Ju Chiang, Wen‐Chung Lee, R Buasom, Suleeporn Sangrajrang15, Supot Kamsa‐ard15, Surapon Wiangnon15, Karnchana Daoprasert, Donsuk Pongnikorn, A Leklob, S Sangkitipaiboon15, Sarayut Lucien Geater, Hutcha Sriplung1, O Ceylan, İskender Kög, Oya Özdemir, T Köse16, T Gurbuz16, F E Karaşahin6, D Turhan, U Aktaş18, Y Halat13, Cankut Yakut, M Altinisik1, Y Cavusoglu13, A Türkköylü, N Üçüncü, Monika Hackl1, A. Zborovskaya, Olga Aleinikova14, K. Henau, Liesbet Van Eycken1, Z. Valerianova7, Mariya Yordanova, Mario Šekerija1, Ladislav Dušek1, Miroslav Zvolský1, Hans H. Storm1, Kaire Innos, Margit Mägi1, Nea Malila, Karri Seppä, Jérémie Jegu16, Michel Velten1, Édouard Cornet1, X. Troussard, Anne‐Marie Bouvier1, Anne‐Valérie Guizard14, Véronique Bouvier14, Guy Launoy, C. Schvartz, Marc Maynadié1, Morgane Mounier1, Anne‐Sophie Woronoff15, M. Daoulas1, M Robaszkiewicz1, Jacqueline Clavel16, Stéphanie Goujon15, Brigitte Bader‐Meunier1, Isabelle Baldi, Camille Pouchieu, B. Amadéo1, Gaëlle Coureau, Sébastien Orazio15, Pierre‐Marie Preux, Faı̈za Rharbaoui1, Émilie Marrer1, Brigitte Trétarre1, Marc Colonna1, Sandrine Plouvier15, Anne Cowppli‐Bony, F. Molinié1, S. Bara15, O. Ganry, B. Lapôtre‐Ledoux1, Pascale Grosclaude, Nadine Bossard, Zoé Uhry7, Freddie Bray1, Marion Piñeros1, Roland Stabenow, Heide Wilsdorf-Köhler1, Andrea Eberle, Sabine Luttmann15, I Löhden, Alice Nennecke1, Joachim Kieschke16, Eunice Sirri1, Katharina Emrich, Sylke Ruth Zeißig, Bernd Holleczek1, Nora Eisemann, Alexander Katalinic, R.A. Asquez, Vijay Kumar14, Eleni Petridou1, Elínborg J. Ólafsdóttir, Laufey Tryggvadóttír1, Kerri M. Clough‐Gorr, Paul M. Walsh, H Sundseth1, Guido Mazzoleni, Fabio Vittadello1, Enzo Coviello1, Rocco Galasso, Giuseppe Sampietro, Angelo Paolo Dei Tos, Michele Magoni1, A Ardizzone, Angelo D’Argenzio, Marine Castaing1, Giuseppe Grosso, Anna Maria Lavecchia1, Attilio Di Spiezio Sardo, G Gola, Luciana V. Gatti1, P. Ricci, Stefano Ciatto15, Diego Serraino, Antonella Zucchetto, M V Celesia, Rosa Angela Filiberti, Fabio Pannozzo1, Anna Melcarne, F Quarta1, Antonio Russo, Giuliano Carrozzi, Claudia Crimi, Luca Cavalieri dʼOro1, M Rognoni1, Mario Fusco1, Maria Francesca Vitale, M. Usala1, Rosanna Cusimano, Walter Mazzucco, Maria Michiara1, Paolo Sgargi, Lorenza Boschetti1, E Borciani1, Pietro Seghini, Milena Maule15, Franco Merletti1, ­Rosario ­Tumino, Pamela Mancuso, Massimo Vicentini1, Tiziana Cassetti16, Romano Sassatelli, Fabio Falcini1, S Giorgetti15, Anna Luisa Caiazzo1, Rossella Cavallo, Sara Piro, D Pirino1, M.L. Contrino, F. Tisano1, Anna Clara Fanetti, S. Maspero15, Simona Carone15, Antonia Mincuzzi, G Candela, T. Scuderi16, Maria Gentilini1, Silvano Piffer15, Stefano Rosso15, A Barchielli, A Caldarella, Fortunato Bianconi1, Fabrizio Stracci1, Paolo Contiero, Giovanna Tagliabue, Massimo Rugge1, Manuel Zorzi1, S Beggiato15, Angelita Brustolin, Franco Berrino1, Gemma Gatta, Milena Sant1, Carlotta Sacerdote, Lucìa Mangone1, Riccardo Capocaccia, Roberta De Angelis, Roberto Zanetti, A Maurina, Santa Pildava15, N. A. Lipunova, Ieva Vincerževskienė, D. Agius, Neville Calleja, Sabine Siesling15, Siri Larønningen15, Birgit Möller1, Agnieszka Dyzmann-Sroka, Maciej Trojanowski1, Stanisław Góźdż15, Ryszard Mężyk, Tomasz Mierzwa16, Łucja Molong1, Jadwiga Rachtan16, Sebastian Szewczyk15, Jerzy Błaszczyk16, Kamila Kępska, Beata Kościańska1, K Tarocińska, M. Zwierko1, Kazimierz Drosik, K M Maksimowicz, E Purwin-Porowska1, E Reca1, J Wójcik-Tomaszewska16, Andrzej Tukiendorf, Monika Grądalska-Lampart1, A.U. Radziszewska18, Anna Gos, Małgorzata Talerczyk1, M Wyborska1, Joanna Didkowska16, Urszula Wojciechowska18, Magdalena Bielska‐Lasota1, G. Forjaz de Lacerda, R.A. Rego, Joana Bastos16, M A Silva7, Luís Antunes1, J Laranja Pontes16, A. Mayer-da-Silva, A. Miranda, Mihaiela L. Blaga10, Daniela Coza, L Gusenkova1, O Lazarevich, O Prudnikova, D M Vjushkov1, A.G. Egorova, А Е Орлов1, L A Kudyakov1, L. V. Pikalova7, J Adamcik16, C. Safaei Diba, Maja Primic‐Žakelj1, Vesna Zadnik14, Nerea Larrañaga, Arantza López de Munain, A A Herrera, R Redondas, Rafael Marcos‐Gragera, M.L. Vilardell Gil, Esther Molina‐Montes1, María‐José Sánchez, P. Franch Sureda, M. Ramos Montserrat1, M.D. Chirlaque12, Carmen Navarro, Marcela Guevara15, Rafael Fernández‐Delgado, Rafael Peris‐Bonet, Marià Carulla1, Jaume Galcerán16, Carmen Alberich, M. Vicente-Raneda1, S. Khan15, David Pettersson, Paul W. Dickman, I Avelina, Katharina Staehelin, Bertrand Camey1, Christine Bouchardy, Robin Schaffar, Henry Clay Frick1, C. Herrmann, Jean‐Luc Bulliard, M. Maspoli-Conconi1, S M Redmond13, Andrea Bordoni, Laura Ortelli1, Arnaud Chioléro, Isabelle Konzelmann, Katarina L. Matthes, Sabine Rohrmann15, John Broggio16, Jem Rashbass16, Deirdre Fitzpatrick, Anna Gavin, Donna York Clark1, Andrew Deas16, D W Huws, Peter D. White, Lisa Montel1, Bernard Rachet1, Adrian Turculet, Richard Stephens, Elizabeth Chalker1, Hai Phung1, Richard Walton, Hui You1, Steven Guthridge15, Fiona Hegi‐Johnson4, Patrick Gordon, Katina D’Onise, K. Priest, B.C. Stokes1, Alison Venn, Helen Farrugia1, Vicky Thursfield14, J. Dowling16, David C. Currow, James A. Hendrix16, Christopher Lewis
1Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
2Population-Based Cancer Registry Section, Division of Surveillance, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan
3Department of Radiology, Radiotherapy and Oncology, Northern State Medical University, Arkhangelsk, Russia
4Cancer Data Registry of Idaho, Boise, ID, USA
5Department of Biostatistics, Université Claude Bernard, Lyon, France
6Ibadan Cancer Registry, University City College Hospital, Ibadan, Dyo State, Nigeria
7Department of Epidemiology, Universidade do Estado do Rio de Janeiro, Maracanã, Rio de Janeiro, Brazil
8National Office for Cancer Prevention and Control and National Central Cancer Registry, National Cancer Center, Beijing, China
9Department of Public Health, Balıkesir University, Balıkesir, Turkey
10Department of Documentation and Quality, Danish Cancer Society, Copenhagen, Denmark
11National Cancer Registration and Analysis Service, Public Health England, London, UK
12French Network of Cancer Registries, Toulouse, France; Registre des hémopathies malignes de la Gironde, Institut Bergonié, Bordeaux, France
13British Columbia Cancer Registry, BC Cancer Agency, Vancouver, BC, Canada
14Netherlands Cancer Registry Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands
15National Registry of Diseases Office, Health Promotion Board, Singapore
16Cancer Council Queensland, Fortitude Valley, QLD, Australia
17Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA
18BPH - Bordeaux population health (Université de Bordeaux - Case 11 - 146 rue Léo Saignat 33076 Bordeaux cedex - France)

Tóm tắt

Từ khóa


Tài liệu tham khảo

2006

2016

2017

Vázquez, 2017, Beating NCDs can help deliver universal health coverage, Lancet, 390, 1473, 10.1016/S0140-6736(17)32470-4

Allemani, 2015, Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2), Lancet, 385, 977, 10.1016/S0140-6736(14)62038-9

Harlan, 2015, Global survival patterns: potential for cancer control, Lancet, 385, 926, 10.1016/S0140-6736(14)62251-0

Walters, 2015, Is England closing the international gap in cancer survival?, Br J Cancer, 113, 848, 10.1038/bjc.2015.265

2015

Weir, 2017, Population-based cancer survival (2001–2009) in the United States: findings from the CONCORD-2 study, Cancer, 123, 4963, 10.1002/cncr.31028

Allemani, 2017, Public health surveillance of cancer survival in the US and world-wide: the contribution of the CONCORD programme, Cancer, 123, 4977, 10.1002/cncr.30854

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210

2000

2013

Sant, 2010, Manual for coding and reporting haematological malignancies, Tumori, 96, i-A32

Steliarova-Foucher, 2005, International classification of childhood cancer, Cancer, 103, 1457, 10.1002/cncr.20910

Matz, 2017, The histology of ovarian cancer: world-wide distribution and implications for international survival comparisons (CONCORD-2), Gynecol Oncol, 144, 405, 10.1016/j.ygyno.2016.10.019

Morton, 2007, Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph), Blood, 110, 695, 10.1182/blood-2006-11-051672

Turner, 2010, InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions, Blood, 116, e90, 10.1182/blood-2010-06-289561

Woods, 2012, Full dates (day, month, year) should be used in population-based cancer survival studies, Int J Cancer, 131, E1120, 10.1002/ijc.27545

2013

2005, International rules for multiple primary cancers, Eur J Cancer Prev, 14, 307, 10.1097/00008469-200508000-00002

2015

Allemani, 2017, Population-based cancer survival in the US: data, quality control and statistical methods, Cancer, 123, 4982, 10.1002/cncr.31025

Estève, 1994

Cutler, 1958, Maximum utilisation of the life table method in analyzing survival, J Chronic Dis, 8, 699, 10.1016/0021-9681(58)90126-7

Brenner, 1996, An alternative approach to monitoring cancer patient survival, Cancer, 78, 2004, 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#

Brenner, 2003, Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates, Br J Cancer, 89, 1260, 10.1038/sj.bjc.6601295

Pohar Perme, 2012, On estimation in relative survival, Biometrics, 68, 113, 10.1111/j.1541-0420.2011.01640.x

Clerc-Urmès, 2014, Net survival estimation with stns, Stata J, 14, 87, 10.1177/1536867X1401400107

Rachet, 2015, Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations, BMC Public Health, 15, 1240, 10.1186/s12889-015-2534-3

Micheli, 2003, Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas, Ann Oncol, 14, 28, 10.1093/annonc/mdg752

Ewbank, 1983, A reducible four-parameter system of model life tables, Popul Studies, 37, 105, 10.1080/00324728.1983.10405927

Brass, 1971, On the scale of mortality, 69

Elandt-Johnson, 1980

Corazziari, 2004, Standard cancer patient population for age standardising survival ratios, Eur J Cancer, 40, 2307, 10.1016/j.ejca.2004.07.002

Stiller, 1990, Trends in survival for childhood cancer in Britain diagnosed 1971–85, Br J Cancer, 62, 806, 10.1038/bjc.1990.383

Greenwood, 1926

Berkson, 1952, Survival curve for cancer patients following treatment, J Am Stat Assoc, 47, 501, 10.1080/01621459.1952.10501187

Dickman, 2006, Interpreting trends in cancer patient survival, J Intern Med, 260, 103, 10.1111/j.1365-2796.2006.01677.x

Coleman, 2014, Cancer survival: global surveillance will stimulate health policy and improve equity, Lancet, 383, 564, 10.1016/S0140-6736(13)62225-4

Allemani C. The importance of global surveillance of cancer survival for cancer control: the CONCORD programme. Cancer Control (in press).

Abdel-Rahman, 2009, What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?, Br J Cancer, 101, 115, 10.1038/sj.bjc.6605401

Ellis, 2012, How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996–2006, Eur J Cancer, 48, 270, 10.1016/j.ejca.2011.10.008

Ho, 2017, What if all patients with breast cancer in Malaysia have access to the best available care: how many deaths are avoidable?, Glob J Health Sci, 9, 32, 10.5539/gjhs.v9n8p32

Pokhrel, 2010, Education, survival and avoidable deaths in cancer patients in Finland, Br J Cancer, 103, 1009, 10.1038/sj.bjc.6605861

Sandiford, 2015, How many cancer deaths could New Zealand avoid if five-year relative survival ratios were the same as in Australia?, Aust NZ J Public Health, 39, 157, 10.1111/1753-6405.12344

Seppä, 2012, Avoidable deaths and random variation in patients' survival, Br J Cancer, 106, 1846, 10.1038/bjc.2012.169

Mirzaei, 2016, Expected years of life lost due to adult cancer mortality in Yazd (2004–2010), Asian Pac J Cancer Prev, 17, 101, 10.7314/APJCP.2016.17.S3.101

Brustugun, 2014, Years of life lost as a measure of cancer burden on a national level, Br J Cancer, 111, 1014, 10.1038/bjc.2014.364

Soerjomataram, 2012, Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions, Lancet, 380, 1840, 10.1016/S0140-6736(12)60919-2

Woods, 2016, No ‘cure’ within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989–2011, Ann Oncol, 27, 2025, 10.1093/annonc/mdw408

Andersson, 2014, Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study, Cancer Epidemiol, 38, 93, 10.1016/j.canep.2013.12.006

Gatta, 2013, Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002, Haematologica, 98, 744, 10.3324/haematol.2012.071597

Ito, 2012, Role of age and tumour stage in the temporal pattern of ‘cure’ from stomach cancer: a population-based study in Osaka, Japan, Cancer Epidemiol, 36, 128, 10.1016/j.canep.2011.12.008

Shack, 2012, “Cure” by age and stage at diagnosis for colorectal cancer patients: a population-based study, Cancer Epidemiol, 36, 548, 10.1016/j.canep.2012.06.011

Coleman, 2013, Why we need global surveillance of cancer survival: the CONCORD programme, 60

Cookson, 2000, Cancer survival, Lancet, 356, 1611, 10.1016/S0140-6736(05)74461-5

2013

Atun, 2015, Expanding global access to radiotherapy, Lancet Oncol, 16, 1153, 10.1016/S1470-2045(15)00222-3

Meara, 2015, Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development, Lancet, 386, 569, 10.1016/S0140-6736(15)60160-X

2017

2013

1991

Berrino, 1995, Basic issues in the estimation and comparison of cancer patient survival, 1

Abdel-Razeq, 2015, Cancer care in Jordan, Hematol Oncol Stem Cell Ther, 8, 64, 10.1016/j.hemonc.2015.02.001

Laurenti, 2000, Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics, 1

Ovcharov, 2000, The improvement of statistical records of the causes of death in Russia, 28

Filippatos, 2016, The quality of death certification practice in Greece, Hippokratia, 20, 19

Haghighi, 2014, Impact of documentation errors on accuracy of cause of death coding in an educational hospital in Southern Iran, HIM J, 43, 35, 10.1177/183335831404300205

Cândida da Cunha, 2017, Assessment of the investigation of ill-defined causes of death in Brazil in 2010, Epidemiol Serv Saude, 26, 1

Antoni, 2016, An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence, Bull World Health Organ, 94, 174, 10.2471/BLT.15.164384

Engeland, 1998, Relative survival of cancer patients: a comparison between Denmark and other Nordic countries, Acta Oncol, 37, 49, 10.1080/028418698423177

1999

Storm, 2008, Cancer survival before and after initiating the Danish Cancer Control plan, Ugeskr Læger, 170, 3065

Engholm, 2016

Storm, 2010, Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results, Acta Oncol, 49, 532, 10.3109/02841861003801148

Yoo, 2008, Cancer control activities in the Republic of Korea, Jpn J Clin Oncol, 38, 327, 10.1093/jjco/hyn026

Choi, 2015, Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea, Br J Cancer, 112, 608, 10.1038/bjc.2014.608

Pech, 2014, Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus, Gastroenterology, 146, 652, 10.1053/j.gastro.2013.11.006

Suh, 2015, Screening and early detection of gastric cancer: East versus West, Surg Clin North Am, 95, 1053, 10.1016/j.suc.2015.05.012

Chang, 2017, Sunrise in melanoma management: time to focus on melanoma burden in Asia, Asia Pac J Clin Oncol, 13, 423, 10.1111/ajco.12670

Brawley, 2017, Accepting the existence of breast cancer overdiagnosis, Ann Intern Med, 166, 364, 10.7326/M16-2850

Marcus, 2015, Conceptualizing overdiagnosis in cancer screening, J Natl Cancer Inst, 107, 1, 10.1093/jnci/djv014

Allemani, 2013, Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study, BMJ Open, 3, e003055, 10.1136/bmjopen-2013-003055

Maringe, 2013, Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007, Acta Oncol, 52, 919, 10.3109/0284186X.2013.764008

Wu, 2013, Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990–2004, PLoS One, 8, e62930, 10.1371/journal.pone.0062930

Sullivan, 2013, New policies to address the global burden of childhood cancers, Lancet Oncol, 14, e125, 10.1016/S1470-2045(13)70007-X

Magrath, 2013, Paediatric cancer in low-income and middle-income countries, Lancet Oncol, 14, e104, 10.1016/S1470-2045(13)70008-1

Mostert, 2011, Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group, Lancet Oncol, 12, 719, 10.1016/S1470-2045(11)70128-0

Pritchard-Jones, 2007, What can we learn from geographical comparisons of childhood cancer survival?, Br J Cancer, 96, 1493, 10.1038/sj.bjc.6603749

Ginsburg, 2017, The global burden of women's cancers: a grand challenge in global health, Lancet, 389, 847, 10.1016/S0140-6736(16)31392-7

Ginsburg, 2017, Changing global policy to deliver safe, equitable and affordable care for women's cancers, Lancet, 389, 871, 10.1016/S0140-6736(16)31393-9

Beaulieu, 2009

Mariotto, 2011, Projections of the cost of cancer care in the United States: 2010–2020, J Natl Cancer Inst, 103, 117, 10.1093/jnci/djq495

Fojo, 2009, How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question, J Natl Cancer Inst, 101, 1044, 10.1093/jnci/djp177

Knaul, 2011

Sullivan, 2011, Delivering affordable cancer care in high-income countries, Lancet Oncol, 12, 933, 10.1016/S1470-2045(11)70141-3

Tangka, 2016, Cost of operating central cancer registries and factors that affect cost: findings from an economic evaluation of Centers for Disease Control and Prevention National Program of Cancer Registries, J Public Health Manag Pract, 22, 452, 10.1097/PHH.0000000000000349

Schmidt, 2015, Public health, universal health coverage, and sustainable development goals: can they coexist?, Lancet, 386, 928, 10.1016/S0140-6736(15)60244-6

López, 2013, Civil registration and vital statistics—everybody's business but nobody's business, Lancet, 381, 1275, 10.1016/S0140-6736(13)60838-7

Setel, 2007, Who counts? 1: A scandal of invisibility: making everyone count by counting everyone, Lancet, 370, 1569, 10.1016/S0140-6736(07)61307-5

2017

Thông tin
Thông tin xuất bản

The Lancet

Tập 391 Số 10125

1023-1075

Thông tin tác giả